Schrödinger outlines 2026 ACV of $222M-$232M while raising drug discovery revenue to $75M-$85M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 5 November 2026
Not scored
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.